Clopidogrel and proton pump inhibitors--where do we stand in 2012? [electronic resource]
Producer: 20120917Description: 2161-71 p. digitalISSN:- 2219-2840
- Animals
- Aryl Hydrocarbon Hydroxylases -- metabolism
- Aspirin -- therapeutic use
- Biotransformation
- Cardiovascular Diseases -- chemically induced
- Clopidogrel
- Cytochrome P-450 CYP2C19
- Drug Interactions
- Drug Therapy, Combination
- Gastrointestinal Hemorrhage -- chemically induced
- Humans
- Platelet Aggregation Inhibitors -- adverse effects
- Proton Pump Inhibitors -- adverse effects
- Risk Assessment
- Risk Factors
- Ticlopidine -- adverse effects
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.